Clinical Trial Update: Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)

View source ↗

Summary

Clinical trial evaluating brain perfusion for Pantothenate Kinase-associated Neurodegeneration (PKAN) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pantothenate Kinase-associated Neurodegeneration

Snippet

Sponsor: Susan J. Hayflick | Conditions: Pantothenate Kinase-associated Neurodegeneration (PKAN) | Status: COMPLETED